Publication: Postpneumonic Empyema in Childhood
| dc.authorscopusid | 55923807300 | |
| dc.authorscopusid | 7005328829 | |
| dc.authorscopusid | 7004296402 | |
| dc.authorscopusid | 13906209200 | |
| dc.contributor.author | Belet, Nursen | |
| dc.contributor.author | Uysal, S. | |
| dc.contributor.author | Bernay, F. | |
| dc.contributor.author | Cürses, N. | |
| dc.date.accessioned | 2020-06-21T09:15:21Z | |
| dc.date.available | 2020-06-21T09:15:21Z | |
| dc.date.issued | 2001 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Belet] Nurşen M., Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Liman Mah, Samsun, Turkey; [Uysal] Serap, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bernay] Ferit, Department of Pediatric Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Cürses] Nuran, Department of Pediatric Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | Fifty-six patients with postpneumonic empyema were treated by sulbactam/ampicillin or cephalothin and netilmicin. Dose of sulbactam/ampicillin was 200mg/kg per day and of cephalothin was 200mg/kg per day, and of netilmicin was 5mg/kg per day. Sulbactam/ampicillin alone was used in 27 patients. Twenty-nine patients were treated with cephalothin plus netilmicin. Days on intravenous antibiotics, days with chest tube, decortication rate, and duration of hospitalization were significantly shorter in sulbactam/ampicillin treatment group compared to cephalothin plus netilmicin group. This study shows that sulbactam/ampicillin is a safe and effective agent in the treatment of postpneumonic empyema in childhood. | en_US |
| dc.identifier.doi | 10.1007/BF02728849 | |
| dc.identifier.endpage | 14 | en_US |
| dc.identifier.issn | 0019-5456 | |
| dc.identifier.issn | 0973-7693 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.pmid | 11237229 | |
| dc.identifier.scopus | 2-s2.0-0035108237 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 11 | en_US |
| dc.identifier.uri | https://doi.org/10.1007/BF02728849 | |
| dc.identifier.volume | 68 | en_US |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | The Indian Journal of Pediatrics | en_US |
| dc.relation.ispartof | Indian Journal of Pediatrics | en_US |
| dc.relation.journal | Indian Journal of Pediatrics | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Childhood | en_US |
| dc.subject | Empyema | en_US |
| dc.subject | Sulbactam/Ampicillin | en_US |
| dc.subject | Treatment | en_US |
| dc.title | Postpneumonic Empyema in Childhood | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
